AWARDPURCHASE ORDERSmall business
Purchase order 75N95023P00162KAREBAY BIOCHEM INC
Overview
Award facts
- Net obligations
- $19.85K
- $19,850of $19.85K potential value
- Outlays (paid to date)
- $19.85K
- $19.85K paid of $19.85K obligated$19,850
- Period of performance
- Apr 10, 2023 to Jun 10, 2023
- Ended
- Modifications
- 0
- Latest action Apr 10, 2023
- Contract type
- Purchase order
- PIID 75N95023P00162
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
200G NON-GMP COMPOUND, N-(3-(2-OXOPYRROLIDIN-1-YL)PROPYL)-4-(6-PHENYLIMIDAZO[1,5-A]PYRAZIN-3- YL)BENZAMIDE, GREATER THAN 95% PURITY BY LCMS AND NMR.
Dates and value
- Award date
- Signed on Apr 10, 2023
- Potential end of performance
- Jun 9, 2023
- Current value
- $19,850Base and exercised options
- Potential value (if all options are exercised)
- $19,850
Obligations by fiscal year of action
- FY2023: $19,850
Total across 1 fiscal year: $19,850
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 10, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationMONMOUTH JUNCTION, NJ
UEIZKCBGTN8DJH7
CAGE code7XKB2
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyKAREBAY BIOCHEM INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NCATS
- Funded from
- Nih cooperative research and development agreementsProgram activities075-5145Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Rockville, Montgomery County, Maryland 20850-2452
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 5
Solicitation and notices
- Solicitation ID
- 75N95023Q00134
- Notices
- Award Notice posted Apr 18, 2023
- Combined Synopsis/Solicitation posted Mar 3, 2023
- Combined Synopsis/Solicitation posted Mar 2, 2023
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Apr 10, 2023Base obligation at award: $19,850
- Latest action
- Apr 10, 2023 — Base awardModification 0; obligation change +$19,850
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $19,850
- Latest action: change in base and all options
- $19,850
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- ChinaCHN
- Place of manufacture
- Mfg outside U.S. - unreasonable costK
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N95C
- Treasury accounts
- 075-X-5145-000
- Object classes
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression